Atheronova, Inc. (AHRO) - OTCQB
AHRO is defunct.
Company Description
AtheroNova Inc. is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. Atherosclerotic plaque, which progressively narrows and blocks arteries, is the main underlying pathology of... More
Sector: Financial
Industry: Real Estate Development
Country: United States